In last trading session, Calidi Biotherapeutics Inc (AMEX:CLDI) saw 1.18 million shares changing hands with its beta currently measuring 0.59. Company’s recent per share price level of $1.45 trading at $0.05 or 3.57% at ring of the bell on the day assigns it a market valuation of $16.93M. That closing price of CLDI’s stock is at a discount of -1713.79% from its 52-week high price of $26.30 and is indicating a premium of 49.66% from its 52-week low price of $0.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.18 million shares which gives us an average trading volume of 425.20K if we extend that period to 3-months.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
Upright in the green during last session for gaining 3.57%, in the last five days CLDI remained trading in the green while hitting it’s week-highest on Tuesday, 11/05/24 when the stock touched $1.45 price level, adding 6.45% to its value on the day. Calidi Biotherapeutics Inc’s shares saw a change of -90.40% in year-to-date performance and have moved 30.63% in past 5-day. Calidi Biotherapeutics Inc (AMEX:CLDI) showed a performance of 34.26% in past 30-days. Number of shares sold short was 0.11 million shares which calculate 1.88 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 73.64% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 9. It follows that stock’s current price would drop -37.93% in reaching the projected high whereas dropping to the targeted low would mean a loss of -37.93% for stock’s current value.
Calidi Biotherapeutics Inc (CLDI) estimates and forecasts
Statistics highlight that Calidi Biotherapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -39.33% of value to its shares in past 6 months, showing an annual growth rate of 74.68% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders
Insiders are in possession of 18.16% of company’s total shares while institution are holding 2.45 percent of that, with stock having share float percentage of 3.00%. Investors also watch the number of corporate investors in a company very closely, which is 2.45% institutions for Calidi Biotherapeutics Inc that are currently holding shares of the company.
